Home › Kidney Diseases
Kidney Diseases clinical trials recruiting in the U.S.
49 studies for Kidney Diseases are recruiting participants at sites across the United States.
Properly functioning kidneys are critical for maintaining good health. Diabetes, high blood pressure, or family history can increase risk of kidney disease.
Cities with the most studies
- Atlanta, GA11 studies
- Houston, TX8 studies
- Orlando, FL7 studies
- Miami, FL6 studies
- Dallas, TX6 studies
- Durham, NC5 studies
- Cedar Rapids, IA5 studies
- New York City, NY5 studies
- Philadelphia, PA5 studies
- Mountain View, CA4 studies
- Boston, MA4 studies
- Denver, CO4 studies
- Los Angeles, CA4 studies
- Nashville, TN4 studies
- Washington, DC4 studies
- Winston-Salem, NC4 studies
- San Francisco, CA3 studies
- Pembroke Pines, FL3 studies
- Indianapolis, IN3 studies
- Salt Lake City, UT3 studies
- Chicago, IL3 studies
- Birmingham, AL3 studies
- Albuquerque, NM3 studies
- Ann Arbor, MI3 studies
- Phoenix, AZ3 studies
- Baltimore, MD3 studies
By state
- Alabama3 studies
- Arizona4 studies
- California13 studies
- Colorado6 studies
- Florida12 studies
- Georgia13 studies
- Illinois5 studies
- Indiana3 studies
- Iowa5 studies
- Maryland6 studies
- Massachusetts5 studies
- Michigan7 studies
- Minnesota4 studies
- Missouri4 studies
- New Jersey5 studies
- New Mexico3 studies
- New York6 studies
- North Carolina9 studies
- Pennsylvania5 studies
- Tennessee6 studies
- Texas12 studies
- Utah3 studies
- Virginia4 studies
Recently updated studies
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases
RecruitingPhase 2
Ages 18 to 115 · All sexes · Updated Sep 29, 2026 · NCT06664814Immune System Related Kidney Disease
RecruitingObservational study
Ages 10 to 99 · All sexes · Updated Sep 28, 2026 · NCT00001979A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RecruitingPhase 2
Ages 18 to 60 · All sexes · Updated Sep 25, 2026 · NCT07541287Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
RecruitingPhase 2
Ages 18 to 90 · All sexes · Updated Sep 22, 2026 · NCT00977977Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT06798909A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
RecruitingPhase 1/2
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06525636Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Sep 21, 2026 · NCT07498335A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06963827PS-002 for the Treatment of IgA Nephropathy in Adults
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 9, 2026 · NCT07182227Evaluate the Impact of Targeted Physical Activity on Clinically Debilitated Dialysis Patients.
Recruiting
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT06374537The Effects of the CF Carrier State on the Kidneys and Pancreas
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Sep 4, 2026 · NCT05474417Duke APOL1 Research Biorepository
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT04160507Enhancing Physical Function in Older Adults With Chronic Kidney Disease
Recruiting
Ages 65 to 100 · All sexes · Updated Aug 26, 2026 · NCT06738394A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 21, 2026 · NCT07006831Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Aug 17, 2026 · NCT06858319Pedal Pump Clinical Trial on Edema V1
Recruiting
Ages 18 and older · All sexes · Updated Aug 12, 2026 · NCT07760363Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Recruiting
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07187479Cooperative Assessment of Late Effects for SCD Curative Therapies
RecruitingObservational study
Ages 4 to 65 · All sexes · Updated Jul 27, 2026 · NCT05153967NAVIGATE Kidney: A Multi-level Intervention to Reduce Kidney Health Disparities
Recruiting
Ages 18 to 75 · All sexes · Updated Jul 24, 2026 · NCT06810622Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
Recruiting
Ages 18 to 80 · All sexes · Updated Jul 6, 2026 · NCT06613568Atacicept in Multiple Glomerular Diseases
RecruitingPhase 2
Ages 2 and older · All sexes · Updated Jun 26, 2026 · NCT06983028A Study of SNP-ACTH (1-39) Gel in Patients With Primary Membranous Nephropathy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 25, 2026 · NCT05696613SPYRAL GEMINI Pilot Study
Recruiting
Ages 18 to 80 · All sexes · Updated Jun 24, 2026 · NCT06907147Study of BHV-1400 in IgA Nephropathy
RecruitingPhase 1
Ages 18 to 65 · All sexes · Updated Jun 23, 2026 · NCT07054684Adia Med of Winter Park LLC Chronic Kidney Disease Research Study
RecruitingPhase 1
Ages 18 to 80 · All sexes · Updated Jun 17, 2026 · NCT07572890From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.